MAJI Nextel Medical Corp.
Communications Services, NEC · OTC · SEC CIK 1492448 · Fiscal year ends 12/31
Financial factors as of 2020-07-31 (2021Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-460.5%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-103,659.0%
ROIC (approx.)—
Asset turnover0.00x
Leverage & solvency
Liabilities / assets46,425.3%
Debt / equity—
Current ratio0.00x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.22x
Accruals ratio-80,708.6%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20202020-04-30 | FY20192019-04-30 | FY20182018-04-30 | FY20122012-04-30 | FY20112011-04-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $0 | $0 | $0 | $0 | $0 |
| SG&A expense | $467,862 | $125,164 | $1,421 | $1.01M | $28,256 |
| Operating income | -$467,862 | -$125,164 | -$1,521 | -$5.99M | -$95,356 |
| Interest expense | $469 | $0 | — | $84,156 | $5,258 |
| Pretax income | -$435,950 | -$125,164 | -$575 | — | — |
| Income tax | $0 | $0 | $0 | — | — |
| Net income | -$435,950 | -$125,164 | -$575 | -$6.07M | -$100,614 |
| EPS (basic) | 0.00 | 0.00 | 0.00 | -0.09 | 0.00 |
| EPS (diluted) | 0.00 | 0.00 | 0.00 | -0.09 | 0.00 |
| Weighted avg. shares (diluted) | 249.80M | 249.78M | 114.21M | 67.22M | 83.82M |
| Balance sheet | |||||
| Cash & equivalents | $0 | $0 | $1,589 | $5,865 | $71,160 |
| Current assets | $58,265 | $0 | $1,589 | $5,865 | $71,160 |
| Total assets | $58,265 | $0 | $1,589 | $5,865 | $71,160 |
| Current liabilities | $444,776 | $214,286 | $90,711 | $280,311 | $102,479 |
| Total liabilities | $444,776 | $214,286 | $90,711 | $280,311 | $102,479 |
| Shareholders' equity | -$386,511 | -$214,286 | -$89,122 | -$274,446 | -$31,319 |
| Shares outstanding | 249.84M | 249.78M | 249.78M | 48.83M | 97.50M |
| Cash flow statement | |||||
| Operating cash flow | -$169,731 | -$9,297 | -$884 | -$215,427 | -$64,246 |
| Investing cash flow | $0 | $0 | $0 | $0 | — |
| Financing cash flow | $169,731 | $7,708 | $0 | $150,132 | $130,488 |
| Stock-based compensation | — | — | — | $820,500 | — |
Free plan shows the latest 5 periods; Pro shows all 6 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.